AstraZeneca Research - Pharmaceutical industry drug research, development of new medicines

Go to navigation
Go to content

A research scientist at work

Our scientists share a common goal: to get life-changing medicines to patients as quickly, safely and efficiently as possible

Latest news

05 July 2010
AstraZeneca and MRC Technology Form Strategic Alliance in Discovery Research, Utilising Shared Compound Libraries

Positioned for the future collapse

We have a robust and expanding pipeline that includes small molecules, biologics and vaccines, addressing areas that represent unmet medical need.
View our pipeline summary

New opportunities collapse

We have many active collaborations with external partners across the globe and we continue to look for innovation & opportunity within and beyond our existing research areas.
Recent collaborations
Upcoming conferences
Seeking solutions collapse
We devote our skills and resources to finding breakthrough therapies in areas where we believe we have particular scientific insight and expertise.
Powerful global reach collapse

AstraZeneca has more than 62,000 employees worldwide. We invest over $4 billion in R&D each year and have over 11,000 people in our R&D organisation.
More about our research facilities

Not signed in

Page tools

Share price

London: 32.38 GBP
New York: 50.44 USD
Stockholm: 368.30 SEK

At 01-Aug-2010 06:56 GMT

Detailed share price

Right patient, right drug, right time

Unlocking the personal potential of medicines

Contact us

Contact us

Email enquiry form

Read more

Recent collaborations

Research ethics

This website is intended for people seeking information on the AstraZeneca International business. If you are in the US you should visit AstraZeneca US.

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.